Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)

NCT02612428 is registered in ClinicalTrials.gov with Vital Therapies, Inc. as lead sponsor.

NCT NCT02612428
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02612428 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized, Open-Label, Multicenter, Controlled, Pivotal Study to Assess Safety and Efficacy of ELAD in Subjects With Alcohol-Induced Liver Decompensation (AILD)
Lead sponsor
Vital Therapies, Inc.
Phase
Phase 3
Overall status
Terminated
Start date
January 31, 2016
Completion date
September 30, 2018
Enrollment
151 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

acute alcoholic hepatitis